The patent, called “Fragment Complementation Assays for G Protein-Coupled Receptors and Their Signaling Pathways,” solidifies Odyssey’s position in complex-based assays, and adds depth to its IP coverage in these two areas, an Odyssey official told CBA News this week.
Affy aims to target downstream genomic-analysis markets with the products gained through its acquisitions of Panomics and True Materials last year, roll out new genotyping assays on its GeneTitan array platform, and consolidate its manufacturing facilities.
Researchers from the National Institutes of Health's Chemical Genomics Center warn that the firefly luciferase enzyme may show enhanced activity with some compounds — potentially leading to false positive results.
Christian Johansson, Gov. Martin O'Malley, Ambrose Schwallie, Jonathan Fleming, Doug Cole, Jean George, Christopher Schaber, Paul Alivisatos, Steve Chu, President Barack Obama, Jay Keasling, Greg Kessler, Jeffrey New